Kume Yohei, Sakuma Hiroko, Sekine Hitomi, Sumikoshi Makoto, Sugimura Yoshihisa, Hosoya Mitsuaki
Department of Pediatrics, Fukushima Medical University, Fukushima, Japan.
Department of Pediatrics, Hoshi General Hospital, Fukushima, Japan.
Clin Pediatr Endocrinol. 2021;30(1):65-69. doi: 10.1297/cpe.30.65. Epub 2021 Jan 5.
Childhood-onset lymphocytic infundibuloneurohypophysitis (LINH) due to infiltration of autoimmune lymphocyte in the neurohypophysis is rarely reported. Its definitive diagnosis requires a pituitary biopsy, which is an invasive procedure. Recently, anti-rabphilin-3A antibody has been reported as a potential diagnostic marker for LINH in adults; however, only a few cases have been reported in children. Here, we present a case of childhood-onset LINH in a 10-yr-old boy identified as anti-rabphilin-3A antibody positive during chronic phase, 9 yr post-onset of central diabetes insipidus (CDI). T1-weighted magnetic resonance imaging (MRI) revealed pituitary stalk thickening and absence of posterior pituitary bright signal spot, and the hormonal responses of the adenohypophysis to GHRH, TRH, CRH, and LHRH revealed no abnormalities during the first admission. MRI at 5 mo post-onset indicated reduced stalk swelling; however, replacement treatment with intranasal desmopressin was continued to counter unimproved CDI. Additionally, GH replacement therapy was also initiated to counter its deficiency. Pituitary re-enlargement was not observed in the subsequent routine MRI, and no increase was observed in the levels of tumor markers during follow-up, which was considered clinically consistent with LINH. Our case study suggests that anti-rabphilin-3A antibody may be considered as a useful diagnostic marker for LINH in children.
由于自身免疫淋巴细胞浸润神经垂体导致的儿童期起病的淋巴细胞性漏斗神经垂体炎(LINH)鲜有报道。其确诊需要垂体活检,这是一种侵入性操作。最近,抗Rabphilin-3A抗体已被报道为成人LINH的潜在诊断标志物;然而,儿童病例报道较少。在此,我们报告一例10岁男孩儿童期起病的LINH,在中枢性尿崩症(CDI)发病9年后的慢性期被鉴定为抗Rabphilin-3A抗体阳性。T1加权磁共振成像(MRI)显示垂体柄增粗且垂体后叶高信号点消失,首次入院时腺垂体对生长激素释放激素(GHRH)、促甲状腺激素释放激素(TRH)、促肾上腺皮质激素释放激素(CRH)和促黄体生成素释放激素(LHRH)的激素反应未显示异常。发病后5个月的MRI显示柄部肿胀减轻;然而,继续采用鼻内去氨加压素替代治疗以应对未改善的CDI。此外,还启动了生长激素替代治疗以应对其缺乏。在随后的常规MRI中未观察到垂体再次增大,随访期间肿瘤标志物水平也未升高,这在临床上被认为与LINH一致。我们的病例研究表明,抗Rabphilin-3A抗体可能被视为儿童LINH的一种有用诊断标志物。